Market News AIOpen the app

BIO-key International shared its Q3 2026 results, showing a 39% rise in software sales and a smaller loss.

ResultsRead the original at SEC EDGAR
Good for BKYI

BIO-key's software license fees rose 39%, and its nine-month loss narrowed 42%. Third-quarter total sales slipped to $1.48 million from $1.55 million, but better margins and new customer wins support improving business prospects.

BKYI · BIO-key International, Inc.

AI read · Good for BKYI

The AI's read

Recurring software sales are becoming a bigger part of BIO-key's business. That helped improve its share of sales left after direct costs, and losses also narrowed over the first 9 months. The weaker quarterly total sales show hardware and service work remains uneven. New government customers and paying off its last note add support, but the company still reports a loss.

Get alerts for BKYI

Follow BIO-key International, Inc. (BKYI) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for BKYI
Free on the App Store and Google Play, or on the web.